It wasn’t long before the tests, which were $3,000 each, showed the virus mutating into four different spike proteins. Patients had anywhere from one to all of them.
“‘How is the vaccine going to work if the spike protein itself is mutating into multiple combinations?’” she asked herself.
“Vaccinating against viruses is not a really a good idea because unfortunately, viruses mutate more than bacteria.”
Hazan was curious about three cases where the virus had completely disappeared by day five. Two of these patients said they had been taking hydroxychloroquine and azithromycin.
On April 2, 2020, Hazan submitted a protocol to treat COVID-19 consisting of hydroxychloroquine, azithromycin, vitamins C, D, and zinc. The Food and Drug Administration (FDA) approved a request to do clinical trials within 24 hours, yet Facebook, Twitter, and Instagram blocked her advertisements for patients.
The few patients Hazan could recruit faced another hurdle as medical authorities warned pharmacists not to prescribe hydroxychloroquine and azithromycin together because of cardiac problems. Her monitoring of patients never revealed such problems.
“These drugs have been given to millions of people with arthritis, and all of a sudden, they’re bad?” she asked.